miR-146a is differentially expressed by myeloid dendritic cell subsets and desensitizes cells to TLR2-dependent

Jennifer Jurkin1, Yvonne M Schichl, Rene Koeffel

  • 1Center of Physiology, Pathophysiology and Immunology, Institute of Immunology, Center of Biomolecular Medicine and Pharmacology, Medical University of Vienna, Vienna, Austria.

Insights

MicroRNA miR-146a, induced by TGF-beta1, is highly expressed in Langerhans cells (LCs) and regulates their immune activation. This finding is crucial for understanding LCs

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Langerhans cells (LCs) and interstitial dendritic cells (intDCs) are related myeloid-derived dendritic cell (DC) subsets with distinct immune functions.
  • Understanding the molecular mechanisms of DC subset specification and function is crucial for cell therapy and immunology.
  • Current knowledge on the specific molecular regulators of LC and intDC differentiation and function is limited.

Purpose of the Study:

  • To investigate the role of microRNA (miRNA) miR-146a in the differentiation and function of human Langerhans cells (LCs) and interstitial dendritic cells (intDCs).
  • To identify the regulatory mechanisms controlling miR-146a expression in LCs, particularly in response to microenvironmental signals.
  • To determine the functional impact of miR-146a on monocyte and DC activation, focusing on Toll-like receptor (TLR) signaling pathways.

Main Methods:

  • Microarray profiling to compare miRNA expression between LCs and intDCs.
  • Analysis of miR-146a expression in monocytes and neutrophil granulocytes.
  • Investigating the role of transcription factor PU.1 and TGF-beta1 in inducing miR-146a expression in LCs.
  • Functional studies involving ectopic expression or silencing of miR-146a in monocytes and DCs to assess its impact on TLR2 signaling and cytokine production.

Main Results:

  • miR-146a is constitutively expressed at higher levels in human LCs compared to intDCs, monocytes, and neutrophil granulocytes.
  • Epidermal microenvironmental signals, specifically TGF-beta1, induce high miR-146a expression in LCs via the transcription factor PU.1.
  • Ectopic miR-146a in monocytes and intDCs inhibits TLR2-mediated downstream signaling and cytokine production without affecting DC maturation.
  • Silencing miR-146a in LCs enhances TLR2-dependent NF-kappaB signaling, indicating miR-146a's inhibitory role.

Conclusions:

  • High constitutive miR-146a levels in LCs are induced by epidermal microenvironmental signals.
  • miR-146a acts as a regulator of monocyte and DC activation, specifically modulating TLR2 signaling.
  • The elevated miR-146a in LCs may protect them from inappropriate activation by commensal bacterial TLR2 triggers at body surfaces.

Related Concept Videos